Comparison of pharmacokinetics, pharmacodynamics, safety, and tolerability of the amyloid β monoclonal antibody solanezumab in Japanese and white patients with mild to moderate alzheimer disease. (Q53324323)
Jump to navigation
Jump to search
scientific article published in January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of pharmacokinetics, pharmacodynamics, safety, and tolerability of the amyloid β monoclonal antibody solanezumab in Japanese and white patients with mild to moderate alzheimer disease. |
scientific article published in January 2012 |
Statements
Comparison of pharmacokinetics, pharmacodynamics, safety, and tolerability of the amyloid β monoclonal antibody solanezumab in Japanese and white patients with mild to moderate alzheimer disease. (English)
1 reference
Kazunori Uenaka
1 reference
Masako Nakano
1 reference
Brian A Willis
1 reference
Stuart Friedrich
1 reference
Lisa Ferguson-Sells
1 reference
Robert A Dean
1 reference
Ichiro Ieiri
1 reference
Eric R Siemers
1 reference
1 January 2012
1 reference
35
1 reference
1
1 reference
25-29
1 reference
Identifiers
1 reference